OLT1177 is a novel drug for treating arthritis, which reduces neutrophil infiltration into the peripheral blood, reduces joint swelling, and inhibits IL-1 secretion in animal models of arthritis (Marchetti et al., 2018b). Here, IL1B is linked to arthritic joint disease.